価格表

在庫・価格 : 2025年04月26日 21時56分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-SARS-CoV/SARS-CoV-2 (COVID-19) ORF7a, Mouse-Mono(3C9)
データシート
GTX632602 GNTジーンテックス
GeneTex International Corporation
25 μl ¥30,000
(未発注)
追加

在庫・価格 : 2025年04月26日 21時56分 現在

Anti-SARS-CoV/SARS-CoV-2 (COVID-19) ORF7a, Mouse-Mono(3C9)

  • 商品コード:GTX632602
  • メーカー:GNT
  • 包装:25μl
  • 価格: ¥30,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Sauvat A et al. On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2. Cell Death Dis 2020 08;11(8):656
Sauvat A et al
2020/01/01
PubMed
2 Ciccosanti F et al. Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection. Antiviral Res 2021 06;190:105064
Ciccosanti F et al
2021/01/01
PubMed
3 Martin-Sancho L et al. Functional landscape of SARS-CoV-2 cellular restriction. Mol Cell 2021 Jun;81(12):2656-2668.e8
Martin-Sancho L et al
2021/01/01
PubMed
4 Arshad N et al. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to downregulate MHC-I surface expression. bioRxiv 2022 May;
Arshad N et al
2022/01/01
PubMed
5 Hou P et al. The ORF7a protein of SARS-CoV-2 initiates autophagy and limits autophagosome-lysosome fusion via degradation of SNAP29 to promote virus replication. Autophagy 2023 Feb;19(2):551-569
Hou P et al
2023/01/01
PubMed
6 Hariharan VN et al. Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection. Proc Natl Acad Sci U S A 2023 Mar;120(11):e2219523120
Hariharan VN et al
2023/01/01
PubMed
7 Arshad N et al. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression. Proc Natl Acad Sci U S A 2023 Jan;120(1):e2208525120
Arshad N et al
2023/01/01
PubMed
  • No.: 1
  • 文献情報:
    Sauvat A et al. On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2. Cell Death Dis 2020 08;11(8):656
    Sauvat A et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Ciccosanti F et al. Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection. Antiviral Res 2021 06;190:105064
    Ciccosanti F et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Martin-Sancho L et al. Functional landscape of SARS-CoV-2 cellular restriction. Mol Cell 2021 Jun;81(12):2656-2668.e8
    Martin-Sancho L et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Arshad N et al. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to downregulate MHC-I surface expression. bioRxiv 2022 May;
    Arshad N et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Hou P et al. The ORF7a protein of SARS-CoV-2 initiates autophagy and limits autophagosome-lysosome fusion via degradation of SNAP29 to promote virus replication. Autophagy 2023 Feb;19(2):551-569
    Hou P et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Hariharan VN et al. Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection. Proc Natl Acad Sci U S A 2023 Mar;120(11):e2219523120
    Hariharan VN et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Arshad N et al. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression. Proc Natl Acad Sci U S A 2023 Jan;120(1):e2208525120
    Arshad N et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed